0 (0%) | 03-29 07:45 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 176.16 | 1-year : | 180.7 |
Resists | First : | 150.82 | Second : | 154.71 |
Pivot price | 147.91 | |||
Supports | First : | 144.55 | Second : | 120.26 |
MAs | MA(5) : | 147.6 | MA(20) : | 148.21 |
MA(100) : | 145.79 | MA(250) : | 160.11 | |
MACD | MACD : | -0.2 | Signal : | -0.2 |
%K %D | K(14,3) : | 55.5 | D(3) : | 41.9 |
RSI | RSI(14): 52.5 | |||
52-week | High : | 190.02 | Low : | 135.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DEO ] has closed below upper band by 37.5%. Bollinger Bands are 43% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 149.53 - 150.32 | 150.32 - 150.99 |
Low: | 146.19 - 147.1 | 147.1 - 147.87 |
Close: | 147.26 - 148.79 | 148.79 - 150.09 |
Thu, 28 Mar 2024
Why the shock news about birth control terrifies me and makes me angry - The Independent
Thu, 28 Mar 2024
Does the contraceptive injection really cause brain tumours? - Cosmopolitan UK
Thu, 28 Mar 2024
Study links birth control, menopause treatment to higher risk for brain tumors - UPI News
Thu, 28 Mar 2024
Contraceptive injections containing progestogens linked to brain tumour risk - Sky News
Wed, 27 Mar 2024
Alert for millions of women taking contraceptive injection as study finds drug may raise risk of brain tumours - Daily Mail
Wed, 27 Mar 2024
Hormone medication could increase risk of brain tumours, French study finds - The Guardian
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 557 (M) |
Shares Float | 2,230 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 10 (%) |
Shares Short | 404 (K) |
Shares Short P.Month | 390 (K) |
EPS | 7.48 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 4.36 |
Profit Margin | 19.6 % |
Operating Margin | 31.5 % |
Return on Assets (ttm) | 8.6 % |
Return on Equity (ttm) | 36.4 % |
Qtrly Rev. Growth | -1.4 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 38.83 |
EBITDA (p.s.) | 12.54 |
Qtrly Earnings Growth | -17.3 % |
Operating Cash Flow | 4,530 (M) |
Levered Free Cash Flow | 1,830 (M) |
PE Ratio | 19.88 |
PEG Ratio | 0 |
Price to Book value | 34.03 |
Price to Sales | 3.83 |
Price to Cash Flow | 18.29 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |